We further evaluated the expression level of variants in tumor vs. non-tumor marginal tissues of 47 patients with breast cancer at the mRNA level to investigate the possible role of ZFX-spliced variants in tumorgenesis. This evidence concerns the gene ZFX and breast cancer.